A consortium is only as strong as it members. As part of membership in MROQC, BCBSM requires active participation from each member of the consortium and attendance by key members at the MROQC collaborative-meetings is an expectation and scored annually.
- A site Clinical Champion is expected to attend all of the MROQC Collaborative Meetings held in a calendar year.
- When the Clinical Champion cannot attend a substitute may be allowed to represent the hospital. A substitute is allowed once a year.
Ideally, the substitute is another Radiation Oncologist from that hospital that treats MROQC patients. Other Radiation Oncologists are acceptable.
- In certain cases (example: a small site with only 1-2 Radiation Oncologists), another physician is acceptable such as the Chief Medical Officer (CMO), the Chief of Quality, or a physician involved in Radiation Oncology cases.
- Residents, Physician Assistants (PA), Nurse Practitioners or non-physicians are not acceptable substitutes.
- For more information, please see the MROQC Clinical Champion Attendance Policy
Physics Lead (or designee)
- The site’s Physics Lead (or designee-i.e. another physicist or a dosimetrist who works on MROQC) is expected to attend all of the MROQC Collaborative Meetings in a calendar year.
Clinical Data Abstractor (CDA or designee)
- A MROQC CDA (or designee-i.e. another CDA or someone who works on MROQC not covering another role at a meeting) is expected to attend all of the MROQC Collaborative Meetings in a calendar year.